Micturition Difficulty and Urinary Retention Associated with Aripiprazole and Citalopram Treatment in a Male Adolescent with Asperger Syndrome

Yalcin, Ozhan

doi:10.1089/cap.2013.0111

Cited by 7 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the reoccurrence of enuresis when aripiprazole was used for the second time indicates that the relationship between aripiprazole and enuresis may not be coincidental. Consistent to our clinical experience, though rarely seen,there are some reports of aripiprazoleinduced urinary retention and enuresis in children (2,4,5,8) . Although SSRIs cause enuresis in most of the cases (9,10) and aripiprazole is a treatment option for enuresis (3,11) , sometimes aripiprazole might be the reason of nocturnal enuresis (2,5,6) .…”

Section: Casesupporting

confidence: 89%

Diurnal Enuresis Secondary to Aripiprazole in A Child With Autistic Disorder: A Case Report

Bilaç¹,

Tahıllıoğlu²,

Uzun³

et al. 2021

BUCH

View full text Add to dashboard Cite

Section: Casesupporting

confidence: 89%

Diurnal Enuresis Secondary to Aripiprazole in A Child With Autistic Disorder: A Case Report

Bilaç¹,

Tahıllıoğlu²,

Uzun³

et al. 2021

BUCH

View full text Add to dashboard Cite

“…It is thought that antipsychotics work through the dopaminergic pathway to control the micturition reflex centrally [ 50 , 51 ], and also, dopamine can activate alpha-1-adrenergic receptors to increase urethral sphincter tone and improve bladder emptying via these receptors [ 52 ] and 5-HT1A receptors in the bladder [ 35 ]. If too much bladder relaxation and increased urethral tone occur, micturition difficulty and even urinary retention may become an issue [ 53 ].…”

Section: Resultsmentioning

confidence: 99%

Optimising the management of children with concomitant bladder dysfunction and behavioural disorders

Eliezer

Lam

Smith

et al. 2022

Eur Child Adolesc Psychiatry

View full text Add to dashboard Cite

Bladder dysfunction and behavioural disorders in children are commonly concomitant; hence, it is difficult to treat each in isolation. Pharmacotherapy is common treatment for behavioural disorders, and these medications may have intended or unintended positive or negative bladder sequelae. This review identifies the literature regarding the effects of behavioural pharmacotherapy on bladder functioning and possible bladder management strategies in children with concomitant behaviour and bladder disorders to enable clinicians to better manage both conditions. A PROSPERO registered PRISMA-guided review of three major databases was performed. After an initial scoping study revealed significant heterogeneity, a narrative approach was undertaken to discuss the results of all relevant cases relating to children being treated with pharmacotherapy for behaviour disorders and outcomes related to bladder function. Studies were screened to identify those that described effects of commonly prescribed medications in children with behavioural disorders such as stimulants, alpha 2 agonists, tricyclic antidepressants (TCA), serotonin and noradrenergic reuptake inhibitors (SNRI), selective serotonin reuptake inhibitors (SSRI) and antipsychotics, and the findings and implications were summarised. The review identified 46 studies relevant to behavioural pharmacotherapy and bladder function (stimulants (n = 9), alpha 2 agonists (n = 2), TCAs (n = 7), SNRIs (n = 8), SSRIs (n = 8) and antipsychotics (n = 6). Six studies focused specifically on bladder management in children with behavioural disorders with concurrent behavioural pharmacotherapy. This review identifies useful factors that may assist clinicians with predicting unintended bladder effects following initiation of behavioural pharmacotherapy to facilitate the best approach to the treatment of bladder dysfunction in children with behavioural disorders. With this evidence, we have provided a useful decision-making algorithm to aide clinicians in the management of these dual pathologies.

show abstract

Linking the evidence between urinary retention and antipsychotic or antidepressant drugs: A systematic review

Walker

Brinchmann

Batura

2015

Neurourology and Urodynamics

View full text Add to dashboard Cite

show abstract

Micturition Difficulty and Urinary Retention Associated with Aripiprazole and Citalopram Treatment in a Male Adolescent with Asperger Syndrome

Cited by 7 publications

References 11 publications

Diurnal Enuresis Secondary to Aripiprazole in A Child With Autistic Disorder: A Case Report

Diurnal Enuresis Secondary to Aripiprazole in A Child With Autistic Disorder: A Case Report

Optimising the management of children with concomitant bladder dysfunction and behavioural disorders

Linking the evidence between urinary retention and antipsychotic or antidepressant drugs: A systematic review

Contact Info

Product

Resources

About